Discover angel-scale biotech: Learn More Eduardo Jorgensen founded Medicsen to improve the care of people with diabetes. Witnessing the struggles of patients taking insulin inspired Eduardo to leave medicine and build a device and an app to simplify the control of blood sugar by patients. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Introduces Eduardo Jorgensen, Founder of Medicsen What Medicsen is all About The S...
May 25, 2022•38 min•Season 6Ep. 21
Angel-scale biotech: Learn More While at Harvard Medical School, Senan Ebrahim was deeply affected by witnessing a still birth. Convinced better data could have avoided the tragedy, he founded Delfina Care with Priyanka Vaidya from EMOTIV, the EEG platform, and his brother Ali Ebrahim, PhD, a former Tech Lead at Google. Senan and Priyanka joined me for a great chat about the exciting things happening in digital health. Highlights: Sal Daher Introduces Senan Ebrahim and Priyanka Vaidya of Delfina...
May 18, 2022•56 min•Season 6Ep. 20
Angels helping biotech startups: Learn More Exited founder Sean Kevlahan, PhD tells the story of Quad Technologies and how an interesting polymer contributed to the explosion of cell therapies in the last decade. Sean gives great advice for biotech founders and investors, and joins Armon Sharei in my pantheon of chemical engineers who are gifted communicators. Sponsored by Purdue University entrepreneurship and Peter Fasse, patents attorney at Fish & Richardson. Highlights: Sal Daher Welcome...
May 11, 2022•40 min•Season 6Ep. 19
Opportunities in Angel-Scale Biotech: Learn More Founder Justin Real tells us how Realplay Sports survived the COVID pause and set itself up to serve booming customer demand in 2022 and 2023. In the 2-year hiatus, Realplay expanded the type customers it can address and brought in partners to enrich its product offering. An inspiring chat with a compelling founder. Sponsored by Purdue University entrepreneuship and Peter Fasse, patent attorney at Fish & Richardson. Highlights: Sal Daher Welco...
May 04, 2022•48 min•Season 6Ep. 18
The promise of angel-scale biotech: Learn More Founder & VC Aaron Michel of 1984.vc on portfolio companies, Reggora, Faimarkit and Relevize and how they exemplify the firm’s approach to seed-stage investing. Aaron also gives Sal a mind-expanding suggestion on angel-scale biotech. Compelling & jargon-free! Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson Sal Daher, CFA Introduces Aaron Michel, Venture Capitalist at 1984.VC Reggora: ...
Apr 27, 2022•48 min•Season 6Ep. 17
Why angel-scale biotech is so promising: Learn More Qiuyan Xu, PhD is a statistician, an entrepreneur and a colleague at Walnut. We talked about the startups she has invested in, her immigrant journey and the work she does at Gravitate AI ( https://www.gravitate.ai ) Sponsors: Purdue University entrepreneurship & Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Introduces Qiuyan Xu, PhD, Statistician, Entrepreneur and Angel Investor Qiuyan Xu Talks About Her Invest...
Apr 20, 2022•52 min•Season 6Ep. 16
Angel-scale biotech is hot: Learn More Slater Victoroff founded Indico Data in his dorm room at Olin in 2012. Two years later Indico had gone through Techstars and was VC-backed. Hear the story of how making deep learning accessible to enterprise customers led to massive growth. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Introduces Slater Victoroff, Founder and CTO of Indico Data Indico Was Founded in a Dorm Roo...
Apr 13, 2022•53 min•Season 6Ep. 15
Angel-scale biotech is exploding: Learn More Practicing urologist and founder Jeremy Wiygul, MD believes millions of people are suffering needlessly due to the inadequate delivery of effective treatment, among these his own wife. Pelex aims to use new technology to integrate existing resources and greatly enhance patient outcomes for people with pelvic floor problems such as incontinence. A fun chat with a compelling founder. Sponsors: Purdue University entrepreneurship and Peter Fasse, patent a...
Apr 06, 2022•32 min•Season 6Ep. 14
Erik Bullen, founder, angel and listener, gives us an overview of his startups and how his life has changed since exiting his last company. Highlights: Sal Daher Introduces Erik Bullen, Angel, Founder & Listener Erik Bullen Is Excited About Focal Point, a SaaS Solution in the Procurement Space “It's one of those stories where he could not find a solution to actually solve this problem so... I'm going to create my own solution and build my own company.” Anders Lillevik of Focal Point Was on t...
Mar 30, 2022•1 hr 7 min•Season 6Ep. 13
Angel-scale biotech is taking off: Learn More Susan Conover of Piction Health, is building an AI to improve results and reduce costs in the treatment of skin conditions. Piction has amassed 500,000 diagnosed images and is already helping primary care physicians interpret skin problems in patients. A great chat with an inspiring founder. Highlights: Sal Daher Thanks Sponsors Purdue University Entrepreneurship and Peter Fasse, Patent Attorney at Fish & Richardson Sal Daher Introduces Susan Con...
Mar 23, 2022•27 min•Season 6Ep. 12
Angel-scale biotech is hot! Learn More Psychiatrist and founder Jacqueline Olds on her startup and her mission to fight loneliness in America. Words of wisdom and lots of laughs in this interview that could actually make your life better. Brought to you by: Purdue University entrpreneurship, and Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Introduces, Jacqueline Olds, M.D., Psychiatrist and Founder Jacqueline and Her Husband, Founded GoodLux Technologies to Help Tr...
Mar 16, 2022•1 hr•Season 6Ep. 11
The Promise of Angel-Scale Biotech: Learn More The miracle-working CEO of portfolio company Finetune Learning is back to tell us about the latest developments in applying artificial intelligence in educational assessments. We also got into remote work and explored how to support younger workers in creating professional networks while working remotely. Sponsored by: Purdue University entrepreneurship Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Expresses Gratitude f...
Mar 09, 2022•1 hr 5 min•Season 6Ep. 10
The Promise of Angel-Scale Biotech: Learn More SPVs (Special Purpose Vehicles) are democratizing startup investing. In this interview with Jeremy Neilson, founder of Assure.co, we discussed how founders and angels can benefit from these increasingly economical platforms and what they mean for the future. Highlights: Sal Daher Introduces Jeremy Neilson Co-Founder of Assure.co Sal and Jeremy Met at an Event Held by Jason Calacanis in 2019 “...the engine of a large number of groups that do angel in...
Mar 02, 2022•51 min•Season 6Ep. 9
The Opportunitites in Angel-Scale Biotech: https://syndicate.angelinvestboston.com/en-us/the-surge-of-opportunities-in-angel-scale-biotech The dynamic duo of founder Adam Martel and super angel Christopher Mirabile are back on the podcast to report on the sale of Gravyty and to discuss Adam’s new startup, Givzey. Highlights: Gravyty Created a New Category How COVID Affected Gravyty Merging Gravyty and Graduway Sal Compares the Gravyty Exit and the Mavrck Exit Selling a Startup to a Private Equit...
Feb 23, 2022•53 min•Season 6Ep. 8
Why Sal Is Bullish on Biotech: Click Here Adam de Sola Pool, a highly successful pioneer in green tech investing in the 1990s, now sees huge opportunities in blue tech. Don’t miss this fascinating tour of ocean technologies conducted by an engaging investor/guide. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Welcomes Back Fellow Angel Investor Adam Pool “...he finds the kind of opportunities [in ocean tech] today ...
Feb 16, 2022•40 min•Season 6Ep. 7
Why Sal Is Bullish on Biotech VeraMorph has a new way to deliver insoluble drugs by mouth. Founder Doug Godfrin, PhD elucidates the promise of accessing the 85% of drugs that are not soluble. Does VeraMorph pass Sal Daher’s screen for angel-scale biotech? Listen and find out. Sponsors: Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson Highlights: Sal Daher, CFA Introduces Doug Godfrin, PhD, Founder of VeraMorph A New Way to Deliver Drugs Orally How VeraMo...
Feb 09, 2022•48 min•Season 6Ep. 6
Click to Learn About Opportunities in Angel-Scale Biotech Diane Stokes, founder and angel investor, is back to update us on her startups. This inspiring triathlete has great ideas for startups who want to scale. Highlights: Sal Daher Welcomes Back Iron Woman Diane Stokes, Founder & Angel This Interview Picks Up Where the Prior Interview Left Off – Back to Wyebot How Wyebot Weathered COVID Diane Stokes and Colleagues Formed a Firm to Help Startups Grow Squadle – Promising Startup in Which Dia...
Feb 02, 2022•36 min•Season 6Ep. 5
Join Sal's Syndicate: https://syndicate.angelinvestboston.com/en-us/the-surge-of-opportunities-in-angel-scale-biotech Artificial intelligence guru Gil Syswerda is back to talk about angel investing and to give practical advice to founders. We closed with entertaining stories from Gil’s career. Highlights: AI Guru Gil Syswerda Is Back to with Tips for Angels & Founders Why Founders Should Value Their Time at $10 per Minute “...I stopped driving...I take an Uber or Lyft because it's not worth ...
Jan 26, 2022•1 hr 15 min•Season 6Ep. 4
Why Sal's Bullish on Angel-Scale Biotech: Learn More Sponsored by Purdue University entrepreneurship and peter Fasse, patent attorney at Fish & Richardson Founder Matt Breen of Rahoo Baby is back to update us on the progress of the company and on their new product, Walk Block. This startup is building a brand around helping parents support the cognitive development of their babies. Highlights: Sal Daher Introduces Matt Breen, Co-founder of Rahoo Baby “...scarcity of information that parents ...
Jan 19, 2022•39 min•Season 6Ep. 3
When Semyon Dukach’s family came to America as refugees from the Soviet Union, they had a hundred dollars to their name. Semyon is now one of Boston’s most consequential VCs. Along the way he founded a couple of startups himself and made some remarkable angel investments that put him in a position to be helping founders with money and time. He has a knack for encouraging founders during the tough times. He’s done some fascinating stuff, like being a member of MIT’s fabled blackjack team, more re...
Jan 12, 2022•52 min•Season 6Ep. 2
Join Sal's Investment Syndicate: Click to Join Listener Robert Nagle is a mathy software guy and an angel investor. We had a great chat which included his perceptions of the risks in biotech investing and also discussed some of the companies in his portfolio. This is an instructive conversation with a thoughtful angel investor. Sponsored by: Purdue University entrepreneurship Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Introduces Listener Robert Nagle, Mathy Softw...
Jan 05, 2022•1 hr•Season 6Ep. 1
When Sid Satish saw his first surgery he was struck by the contrast between the advanced technologies in use side by side with ancient practices such as the negotiation over how much patient blood has been lost. He saw an opportunity to apply technology to create an informed calculation of blood loss. This was in 2011, now this technology runs on iPad Pros and is in use at 30 hospitals. In the fall of 2021 Gauss Surgical was acquired by Stryker so it’s time to re-launch this compelling interview...
Dec 29, 2021•16 min•Season 5Ep. 52
Join Sal's Investment Syndicate: Click to Join Salvatore Viscomi, MD founded his own startup and is now with GoodCell which isolates and stores cells of healthy patients who may need them for future cell therapies. The startup is founded by David Scadden, MD of the Harvard Stem Cell Institute. A truly informative interview. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney. Highlights: Sal Daher, CFA Introduces Salvatore Viscomi, MD, Physician, Founder & Invest...
Dec 22, 2021•39 min•Season 5Ep. 51
Sal's Syndicate: Click to Join Virtual visits & robotics to improve greatly the recovery of stroke patients. Chrissy Glover & her startup, Imago Rehab, are taking to market technology from Harvard's Biodesign Lab informed by deep experience in how stroke rehabilitation is done now. Highlights: Sal Daher Introduces Chrissy Glover, Co-Founder of Imago Rehab “...they've had a stroke maybe a year ago, and their hand is just stuck in this fist position.” “It's well understood that what is req...
Dec 15, 2021•43 min•Season 5Ep. 50
Sal's Investment Syndicate: Click to Join Harvard’s Tom Eisenmann is the author of Why Startups Fail: A New Roadmap for Entrepreneurial Success . We discussed valuable lessons from the book and how they might apply to biotech startups. Highlights: Sal Daher Introduces Prof. Tom Eisenmann of the Harvard Business School, Author of Why Startups Fail Howard Stevenson’s 400X Return Contrasting Brad Feld’s Book with Prof. Tom Eisenmann’s Book Sal Daher’s Favorite Part of the Book: Failing “[failed] fo...
Dec 08, 2021•50 min•Season 5Ep. 49
Join Sal's Syndicate: Click to Join Genius founder Sam Bogoch of Axle.ai returns to the podcast to tells us the secrets of equity crowdfunding. Axle.ai helps enterprises with massive video files make them usable. The startup has found great success on Republic and Sam has wisdom to share. Highlights: Sal Daher Introduces Sam Bogoch Founder of Axle.ai Who Is a Returning Guest Sam Bogoch’s Back Story Is on Another Episode Titled “Boy Genius, MD & Founder” Axle.ai addresses the accumulation of ...
Dec 01, 2021•41 min•Season 5Ep. 48
Join Sal's Syndicate: https://www.angelinvestboston.com/our-syndicates Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish & Richardson Hesitant about investing in biotech startups? Founder Çağrı Savran and I discuss the unique opportunities and requirements of angel-scale life science startups. This is the first in a series of biotech angel bootcamps. Highlights: Podcast Sponsored by Purdue University Entrepreneurship and Peter Fasse, Patent Attorney Sal...
Nov 24, 2021•43 min•Season 5Ep. 47
Sal' Syndicate: Click to Join Artificial General Intelligence (AGI) is the whole ball game. Whoever gets it first will rule. Who’s ahead and how to bet on them; this is only part of the excellent second chat with AI wiz Gil Syswerda. Highlights: Sal Daher Introduces Second Installment of Interview – AI and the Future Sponsors: Purdue University entrepreneurship, and Peter Fasse, patent attorney at Fish & Richardson “History is full of financial firms devising algorithms that work great in th...
Nov 17, 2021•1 hr 22 min•Season 5Ep. 46
Sponsors: Purdue University entrepreneurship Peter Fasse, patent attorney at Fish & Richardson Mostly diagnosed in late stages, ovarian cancer is a silent killer of women. Oriana Papin-Zoghbi of AOA Dx aims to defeat this threat. Fresh out of Y Combinator, the team is making impressive headway in commercializing a promising technology from McGill University. Highlights: Sal Introduces Sponsors, Purdue University Entrepreneurship & Peter Fasse, Patent Attorney Sal Daher, CFA Welcomes Oria...
Nov 10, 2021•50 min•Season 5Ep. 45
Sal's Syndicate: https://www.angelinvestboston.com/our-syndicates Sponsored by: Purdue University Entrepreneurship Peter Fasse, patent attorney at Fish & Richardson The best measure of a founder is how much she can get done with limited resources. By this metric, Bryanne Leeming is an outstanding founder. Two years before she had a paper prototype and vague hopes for a Kickstarter program. At the time we spoke she had a sleek physical product that’s gaining market. She also had the software ...
Nov 03, 2021•33 min•Season 5Ep. 44
